Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study is being carried out to see if ZD1839 is effective in treating metastatic breast
cancer in combination with Nolvadex, and if so, how it compares with Nolvadex alone.